20. März 2026
The topics discussed include the program content, the admission procedure as well as the admission requirements.
(c) Biolution
20.3.2026, 16.00–17.00 Uhr, Online via Zoom
Are you looking for an English‑language, research‑focused master’s program that brings together cancer biology, immunology, drug discovery, human genetics and stem cell research?
Our program is unique in Austria in this combination. You will explore the molecular and cellular mechanisms of human diseases and gain insight into how innovative therapeutic strategies are developed. In addition, you will also work with current topics such as drug discovery and biomedical big data analysis. Throughout your studies, you benefit from a strong national and international network at university level, connecting you with leading research groups and biotech partners. The application deadline for the academic year 2026/27 is March 31, 2026.
We cordially invite you to participate in the online information session (OIS):
The link to the OIS: https://hcw-ac-at.zoom.us/j/98942333591?pwd=SanaayKLUqAakbzSlNp5bOPnrAk1wF.1
Meeting-ID: 989 4233 3591
Passwort: 447630
Join via SIP
98942333591@zoomcrc.com
Join via Skype for Business
https://hcw-ac-at.zoom.us/skype/98942333591
No registration is required. Head of Degree Program Florian Sparber looks forward to seeing you there.
More information about the master's degree program Molecular Biotechnology.